Literature DB >> 21484164

Modulation of inflammatory signaling pathways by phytochemicals in ovarian cancer.

Mi-Kyung Kim1, Kidong Kim, Jae Yong Han, Jeong Mook Lim, Yong Sang Song.   

Abstract

Inflammation has been suggested to be involved in cancer development and progression. Many clinical and experimental studies have shown that inflammation could contribute to ovarian carcinogenesis through activation of the NF-κB and AP-1 pathways by chronic inflammatory mediators. Phytochemicals, which are natural compounds derived from fruits and vegetables, have shown anti-inflammatory and anti-cancer effects. Due to their relatively low toxicity and easy accessibility, phytochemicals have been investigated for their chemopreventive potential against various cancers. In this review, we discuss the role of phytochemicals in preventing ovarian cancer through anti-inflammatory mechanisms.

Entities:  

Year:  2011        PMID: 21484164      PMCID: PMC3092902          DOI: 10.1007/s12263-011-0209-y

Source DB:  PubMed          Journal:  Genes Nutr        ISSN: 1555-8932            Impact factor:   5.523


  68 in total

1.  Use of resveratrol to improve the effectiveness of cisplatin and doxorubicin: study in human gynecologic cancer cell lines and in rodent heart.

Authors:  Youssef A Rezk; Sujata S Balulad; Rebecca S Keller; James A Bennett
Journal:  Am J Obstet Gynecol       Date:  2006-04-21       Impact factor: 8.661

2.  Phenoxodiol, an experimental anticancer drug, shows potent antiangiogenic properties in addition to its antitumour effects.

Authors:  Jennifer R Gamble; Pu Xia; Christopher N Hahn; Jenny J Drew; Christopher J Drogemuller; David Brown; Mathew A Vadas
Journal:  Int J Cancer       Date:  2006-05-15       Impact factor: 7.396

3.  Combined inhibitory effects of green tea polyphenols and selective cyclooxygenase-2 inhibitors on the growth of human prostate cancer cells both in vitro and in vivo.

Authors:  Vaqar Mustafa Adhami; Arshi Malik; Najia Zaman; Sami Sarfaraz; Imtiaz Ahmad Siddiqui; Deeba Nadeem Syed; Farrukh Afaq; Farrukh Sierre Pasha; Mohammad Saleem; Hasan Mukhtar
Journal:  Clin Cancer Res       Date:  2007-03-01       Impact factor: 12.531

4.  Pro-apoptotic effect and cytotoxicity of genistein and genistin in human ovarian cancer SK-OV-3 cells.

Authors:  Eun Jeong Choi; Taehee Kim; Myeong-Sok Lee
Journal:  Life Sci       Date:  2007-01-19       Impact factor: 5.037

5.  Chemopreventive effect of curcumin, a naturally occurring anti-inflammatory agent, during the promotion/progression stages of colon cancer.

Authors:  T Kawamori; R Lubet; V E Steele; G J Kelloff; R B Kaskey; C V Rao; B S Reddy
Journal:  Cancer Res       Date:  1999-02-01       Impact factor: 12.701

6.  Role of p53 and NF-kappaB in epigallocatechin-3-gallate-induced apoptosis of LNCaP cells.

Authors:  Kedar Hastak; Sanjay Gupta; Nihal Ahmad; Mukesh K Agarwal; Munna L Agarwal; Hasan Mukhtar
Journal:  Oncogene       Date:  2003-07-31       Impact factor: 9.867

7.  Hypoxia enhances LPA-induced HIF-1alpha and VEGF expression: their inhibition by resveratrol.

Authors:  Soon Young Park; Kang Jin Jeong; Jangsoon Lee; Dae Sung Yoon; Wahn Soo Choi; Yong Kee Kim; Jeung Whan Han; Yoon Mee Kim; Bum Kyeong Kim; Hoi Young Lee
Journal:  Cancer Lett       Date:  2007-10-04       Impact factor: 8.679

Review 8.  Curcumin as "Curecumin": from kitchen to clinic.

Authors:  Ajay Goel; Ajaikumar B Kunnumakkara; Bharat B Aggarwal
Journal:  Biochem Pharmacol       Date:  2007-08-19       Impact factor: 5.858

9.  Inhibition of cell growth and VEGF expression in ovarian cancer cells by flavonoids.

Authors:  Haitao Luo; Bing-Hua Jiang; Sarah M King; Yi Charlie Chen
Journal:  Nutr Cancer       Date:  2008       Impact factor: 2.900

10.  trans-3,4,5'-Trihydroxystibene inhibits hypoxia-inducible factor 1alpha and vascular endothelial growth factor expression in human ovarian cancer cells.

Authors:  Zongxian Cao; Jing Fang; Chang Xia; Xianglin Shi; Bing-Hua Jiang
Journal:  Clin Cancer Res       Date:  2004-08-01       Impact factor: 12.531

View more
  8 in total

Review 1.  The Role of Secondary Metabolites on Gynecologic Cancer Therapy: Some Pathways and Mechanisms.

Authors:  Mürşide Ayşe Demirel; İpek Süntar
Journal:  Turk J Pharm Sci       Date:  2017-11-20

2.  Anti-Inflammatory Effects of Novel Standardized Solid Lipid Curcumin Formulations.

Authors:  Pragati P Nahar; Angela L Slitt; Navindra P Seeram
Journal:  J Med Food       Date:  2014-12-09       Impact factor: 2.786

3.  Genistein suppresses the inflammation and GSK-3 pathway in an animal model of spontaneous ovarian cancer

Authors:  Füsun Erten; Engin Yenice; Cemal Orhan; Beşir Er; Pınar Demirel Öner; Patrick Brice Defo Deeh; Kazım Şahin
Journal:  Turk J Med Sci       Date:  2021-06-28       Impact factor: 0.973

4.  BRCA1 185delAG Mutation Enhances Interleukin-1β Expression in Ovarian Surface Epithelial Cells.

Authors:  Kamisha T Woolery; Mai Mohamed; Rebecca J Linger; Kimberly P Dobrinski; Jesse Roman; Patricia A Kruk
Journal:  Biomed Res Int       Date:  2015-08-19       Impact factor: 3.411

Review 5.  Genistein as a Potential Anticancer Agent against Ovarian Cancer.

Authors:  Jung-Yun Lee; Hee Seung Kim; Yong-Sang Song
Journal:  J Tradit Complement Med       Date:  2012-04

6.  Anti-Inflammatory Effects of Curcumin on Insulin Resistance Index, Levels of Interleukin-6, C-Reactive Protein, and Liver Histology in Polycystic Ovary Syndrome-Induced Rats.

Authors:  Shima Mohammadi; Latifeh Karimzadeh Bardei; Vida Hojati; Azita Ghorbani Ghorbani; Mohammad Nabiuni
Journal:  Cell J       Date:  2017-08-19       Impact factor: 2.479

7.  Bioinformatics Analysis on Molecular Mechanism of Green Tea Compound Epigallocatechin-3-Gallate Against Ovarian Cancer.

Authors:  S Xinqiang; Z Mu; C Lei; L Y Mun
Journal:  Clin Transl Sci       Date:  2017-05-23       Impact factor: 4.689

8.  Phytoestrogen genistein hinders ovarian oxidative damage and apoptotic cell death-induced by ionizing radiation: co-operative role of ER-β, TGF-β, and FOXL-2.

Authors:  Yasmin Hamdy Haddad; Riham S Said; Rehab Kamel; Engy M El Morsy; Ebtehal El-Demerdash
Journal:  Sci Rep       Date:  2020-08-11       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.